Cellebrite DI (CLBT) Enterprise Value (2020 - 2025)

Cellebrite DI (CLBT) has reported Enterprise Value for 6 consecutive years, with -$285.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Enterprise Value rose 17.34% year-over-year to -$285.5 million; the TTM figure through Dec 2025 stood at -$285.5 million (up 17.34% YoY), while the FY2025 annual figure was -$285.5 million, up 17.34% from the prior year.
• Enterprise Value came in at -$285.5 million for Q4 2025 at Cellebrite DI, down from -$281.4 million in the prior quarter.
• The five-year high for Enterprise Value was -$84.6 million in Q3 2022, with the low at -$345.4 million in Q4 2024.
• Average Enterprise Value over 5 years is -$156.3 million, with a median of -$129.0 million recorded in 2022.
• The largest YoY upside for Enterprise Value was 26.1% in 2025 against a maximum downside of 106.35% in 2025.
• Year by year, Enterprise Value stood at -$146.0 million in 2021, then gained by 9.38% to -$132.3 million in 2022, then plunged by 72.51% to -$228.2 million in 2023, then plunged by 51.35% to -$345.4 million in 2024, then gained by 17.34% to -$285.5 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$285.5 million, -$281.4 million, and -$179.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.